time loop was founded in 2013 as a working group between researchers, patients and therapists.

At that time, the AG's goal was to understand Morgellons' disease and to develop and publicise an effective prophylaxis using the possibilities of milieu medicine. 

​

Since the founding of the AG, in addition to Morgellon's prophylaxis, a number of preparations have been developed in cooperation with the Austrian company biopure, which, as dietary supplements, can help to prevent a number of diseases that were previously considered incurable from breaking out in the first place. They are all typical pre-diseases that usually occur before a massive Morgellon outbreak occurs.

​

As a result of the WG's work on the morgellon complex, innovative prophylactic solutions are now available for the following clinical pictures:

​

• Cryptopyroluria

• Shifts in the candida milieu

• Functional disorders of the liver

• Herpes as a secondary disease for the purpose of excreting candidate-related fungal toxins

• Lyme disease

• The secondary detoxification symptoms neurodermatitis/hay fever/asthma

​

The Morgellons disease has been shown to be caused by a transhumanist technology. These technologies use self-replicating and self-mounting half-technological, half-biological entities. In trying to understand this transhumanist concept, other artificial particles came into the focus of the AG. This led to a new understanding of degenerative ageing diseases. Through the WG's involvement with the complex of mercury poisoning, copper deficiency, heavy metal pollution and the availability of piezoelectric nanoparticles, innovative prophylactic solutions are now available for the following conditions:

 

• Alzheimer's disease

• Dementia

• Creutzfeldt Jakob

• Parkinson's disease

• ALS

 

Corresponding preparations are in the approval process, but are currently not yet available for purchase.

Because of the devastating side effects of antibiotics on the physical milieu that have been revealed in the course of research, the WG has also done its best to develop an infopathy-based and thus non-milieu-damaging alternative to antibiotics.

In response to the reconstruction of the Spanish flu virus by US-American interest groups, an influenza drug was developed based on the findings of milieu medicine that is specifically designed for the symptoms of Spanish flu, i.e. that which ensures that the risk of bacterial co-infection, i.e. the aspect of the disease that caused so many deaths in the Spanish flu, can be counteracted preventively by moistening and soothing the mucous membranes, but which has also been shown anecdotally to be effective in alleviating the symptoms of conventional infections without combating the virus as such.